Patent assignee · US · COMPANY

Corridor Pharmaceuticals, Inc.

1Patents
1Active
1Granted
42Portfolio score

Filing activity: Jul 26, 2011 → Jul 26, 2011

Most-cited patents

PatentTitleAreaCited byStatus
US8894970B2 Arginase inhibitors and methods of use thereof Emerging Cross-Sectional Technologies 22 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.